Financials

  • Market Capitalization 12.47 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-45.32
Fiyat/satışlar oranı
13.63

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
703
BBIO
BridgeBio Pharma, Inc. - Common Stock
77.02 USD-2.11%-5.97%-8.98%+35.12%15.06 B USD
766
EXEL
Exelixis, Inc. - Common Stock
54.17 USD-1.97%-0.44%-4.04%+38.76%13.42 B USD
802
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
64.64 USD-1.00%-3.09%+4.14%+12.34%12.51 B USD
811
CORT
Corcept Therapeutics Incorporated - Common Stock
113.71 USD-2.75%-6.42%+19.69%+54.98%12.29 B USD

Haberler